Industry

DUBLIN–(BUSINESS WIRE)–The “Diabetes Supplements Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering. This report on the global diabetes supplements market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Injection Pen Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the global injection pen market. The global injection pen market is expected to grow from $43.56 billion in 2021 to $46.70 billion in 2022 … [Read more…]

LAUSANNE, Switzerland–(BUSINESS WIRE)–MindMaze, a global pioneer in neurotechnology and digital therapeutics (DTx) for neurological recovery and care, has been recognized as one of Switzerland’s Best Managed Companies in 2022. This programme, sponsored by Deloitte Private, SIX Swiss Exchange, and Julius Baer, awards Swiss companies who operate at the highest level of business performance. “We are … [Read more…]

WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties, Inc. (NYSE:LTC) will release second quarter earnings on Thursday, July 28, 2022 after market close. LTC will conduct a conference call on Friday, July 29, 2022 at 8:00 a.m. Pacific / 11:00 a.m. Eastern, to provide commentary on the performance and operating results for the quarter ended June 30, 2022. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Bladder Cancer Drugs Global Market Report 2022, Type, Application, Distribution Channel” report has been added to ResearchAndMarkets.com’s offering. The global bladder cancer drugs market is expected to grow from $1.98 billion in 2021 to $2.35 billion in 2022 at a compound annual growth rate (CAGR) of 19.1%. The market is expected to reach … [Read more…]

BURLINGAME, Calif.–(BUSINESS WIRE)–Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX) (“Entasis”) at a price of $2.20 per share, net to the seller in cash, without interest and less required withholding taxes, expired at … [Read more…]

WESTLAKE, Ohio–(BUSINESS WIRE)–Nordson Corporation (Nasdaq: NDSN) today announced a strategic business segment realignment that reinforces the Company’s focus on its long-term profitable growth strategy. The Company will reorganize into three financial reporting segments effective August 1, 2022: Industrial Precision Solutions (IPS) led by Jeffrey A. Pembroke, Executive Vice President; Medical and Fluid Solutions (MFS) led … [Read more…]

RICHMOND, Va.–(BUSINESS WIRE)–Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system, today announces that its therapeutic program Adimune™, has successfully completed a toxicology study that indicates the safety profile of ADI™-100, the Company’s immunotherapeutic technology drug that addresses rejection of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “IVD Raw Materials Market – Global Outlook & Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. With the rise in chronic conditions and patient populations, the demand for diagnostics and laboratory tests increases. The growing demand for antigen and antibody-based tests that increased during COVID-19 led to its major market share. The … [Read more…]

Analyses of the first three patients at 6 months post-treatment showed increases in white matter and myelin and improvements on validated functional scales To date, 5 patients have been treated in the ongoing Phase 1/2 First-in-Human clinical trial with favorable safety and tolerability Encouraging early data support further development of rAAV-Olig001-ASPA as a potential therapeutic … [Read more…]